Investor Relations
The primary objective of our Investor Relations activities is to communicate with the financial community, especially private as well as institutional investors and analysts, in an open and timely manner. Our focus is on conducting a correct, comprehensive and fair dialogue.
| IR EVENT
January 19, 2010  _CA Cheuvreux German Corporate Conference (528 kb)> More meetings | PRESENTATION OF FINANCIAL RESULTS
October 26, 2009 Results 3rd Quarter 2009 (1.2 MB)> Results of prior quarters |
"Merck is an innovative pharmaceutical and chemical company with a portfolio of complementary business dynamics that will drive the quality growth of the Group going forward."
Dr. Michael Becker
Dr. Michael Becker
IR NEWS
11/30/2009Merck KGaA Receives Refuse to File Letter from FDA on Cladribine Tablets New Drug Application
UPCOMING DATES
02/23/2010Publication of business results for Q4 / FY 2009 (Analysts Conference)
